Testing Times

Dr Victor Chua, Partner at Mansfield Advisors, looks at the potential for increased M&A activity and outsourcing in the independent pathology market In our last article, we looked at Monitor’s proposals to drastically cut the tariff for non-emergency orthopaedic procedures. It looks like the proposal has been taken off the table for now. On 6th…

Membership Required

You must be a HM Subscriber to view this content.

Subscribe Now »

Already have an account?